导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.66% | 4551/4982 |
| 近一周 | -1.90% | 3088/5419 |
| 近一月 | -2.20% | 1957/5423 |
| 近一季 | -7.86% | 2713/5376 |
| 近半年 | -16.23% | 4487/5131 |
| 近一年 | -22.40% | 4354/4741 |
| 近两年 | 3.03% | 4018/4208 |
| 近三年 | -27.01% | 3556/3661 |
| 成立以来 | 216.82% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.58% 4169/5130 |
-2.61% 3643/5464 |
- - |
- - |
| 2025 | 9.96% 3976/5130 |
5.34% 1652/4624 |
5.41% 1204/4802 |
5.48% 4391/4970 |
-6.12% 3812/5130 |
| 2024 | -12.26% 3742/4618 |
-4.81% 2598/4340 |
-8.85% 3842/4442 |
7.01% 3285/4550 |
-5.50% 3316/4618 |
| 2023 | -20.74% 2727/4216 |
2.49% 1647/3759 |
-10.85% 3411/3909 |
-6.53% 1718/4055 |
-7.19% 3040/4209 |
| 2022 | -28.10% 2172/3578 |
-17.43% 1374/2804 |
6.40% 1728/3205 |
-15.21% 2411/3430 |
-3.47% 2289/3570 |
| 2021 | -4.10% 1182/2717 |
-7.96% 1322/1745 |
12.49% 786/2232 |
-6.13% 1327/2560 |
-1.33% 1762/2708 |
| 2020 | 73.31% 243/1596 |
1.24% 321/1036 |
31.79% 202/1256 |
11.89% 523/1472 |
16.09% 551/1690 |
| 2019 | 48.00% 269/926 |
27.33% 672/3054 |
0.66% 1035/3201 |
5.25% 482/939 |
9.71% 387/1014 |
| 2018 | -34.50% 494/668 |
- - |
- - |
- - |
-10.58% 2076/2977 |
| 2017 | 29.15% 67/531 |
- - |
- - |
- - |
- - |
| 2016 | -11.94% 187/455 |
- - |
- - |
- - |
- - |
| 2015 | 57.83% 138/433 |
- - |
- - |
- - |
- - |
| 2014 | 35.08% 92/432 |
- - |
- - |
- - |
- - |
| 2013 | 17.91% 154/398 |
- - |
- - |
- - |
- - |
| 2012 | -4.35% 431/459 |
- - |
- - |
- - |
- - |
| 2011 | -29.26% 328/392 |
- - |
- - |
- - |
- - |
| 2010 | -9.66% 318/335 |
- - |
- - |
- - |
- - |
| 2009 | 103.12% 8/270 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0224 | 56.52% |
| 招商创新增长混合A | 1.0959 | 55.91% |
| 招商创新增长混合C | 1.0424 | 55.61% |
| 招商品质成长混合A | 1.0640 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6963 | 50.99% |
| 华泰柏瑞医疗健康C | 2.6332 | 50.85% |
| 大摩优悦安和混合A | 0.9071 | 48.05% |
| 大摩优悦安和混合C | 0.8904 | 47.91% |
| 中信建投医药健康A | 0.8091 | 39.62% |
| 中信建投医药健康C | 0.7713 | 39.35% |
| 银华领先策略混合 VS. 长安宏观策略混合A(740001) |